SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-19-007852
Filing Date
2019-05-06
Accepted
2019-05-06 10:03:02
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-1/A ff12019a1_biondvaxpharma.htm F-1/A 2764756
2 REPLY TO STAFF COMMENT LETTER OF APRIL 5, 2019 ff12019a1ex10-15_biondvax.htm EX-10.15 7264
3 CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M ff12019a1ex23-1_biondvax.htm EX-23.1 2164
4 GRAPHIC img001.jpg GRAPHIC 14288
5 GRAPHIC img002.jpg GRAPHIC 32910
6 GRAPHIC img003.jpg GRAPHIC 34794
7 GRAPHIC img004.jpg GRAPHIC 4643
  Complete submission text file 0001213900-19-007852.txt   2895003
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-230484 | Film No.: 19798286
SIC: 2836 Biological Products, (No Diagnostic Substances)